FABP4 and breast cancer: Secondly, to explore whether metformin treatment affected LIPEC vessels, we quantified the percentage of FABP4+ LIPEC vessels in 25 BC patients with similar clinical and pathological characteristics (Supplementary Data 1) and derived from the same cohort as used for the survival analysis.